-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.
作者信息
Onaindia Arantza, de Villambrosía Sonia González, Prieto-Torres Lucía, Rodríguez-Pinilla Socorro M, Montes-Moreno Santiago, González-Vela Carmen, Piris Miguel A
机构信息
Hospital Universitario Marqués de Valdecilla, Pathology Department, Santander
Hospital Universitario Marqués de Valdecilla, Hematology Department, Santander.
出版信息
Haematologica. 2019 Apr;104(4):e158-e162. doi: 10.3324/haematol.2018.205880. Epub 2018 Oct 25.
Abstract
摘要
相似文献
1
-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.
Haematologica. 2019 Apr;104(4):e158-e162. doi: 10.3324/haematol.2018.205880. Epub 2018 Oct 25.
2
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.
3
Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Br J Haematol. 2019 Aug;186(3):e28-e31. doi: 10.1111/bjh.15860. Epub 2019 Mar 14.
4
Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Biomark Med. 2015;9(8):719-22. doi: 10.2217/BMM.15.37. Epub 2015 Jul 30.
5
Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
Blood. 2022 Jan 20;139(3):465. doi: 10.1182/blood.2021013693.
6
Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Am J Surg Pathol. 2021 Apr 1;45(4):550-557. doi: 10.1097/PAS.0000000000001614.
7
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements.
Blood. 2018 Sep 27;132(13):1386-1398. doi: 10.1182/blood-2018-03-838524. Epub 2018 Aug 9.
8
DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
Hum Pathol. 2024 Aug;150:58-66. doi: 10.1016/j.humpath.2024.07.002. Epub 2024 Jul 4.
9
DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
Histopathology. 2022 Jan;80(2):446-449. doi: 10.1111/his.14448. Epub 2021 Sep 5.
10
Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
Histopathology. 2017 Jun;70(7):1173-1175. doi: 10.1111/his.13163. Epub 2017 Mar 10.
引用本文的文献
1
Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype.
Int J Mol Sci. 2025 Jun 19;26(12):5871. doi: 10.3390/ijms26125871.
2
Molecular heterogeneity of CD30 peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study.
EBioMedicine. 2025 May;115:105693. doi: 10.1016/j.ebiom.2025.105693. Epub 2025 Apr 10.
3
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia.
Nat Commun. 2025 Feb 10;16(1):1480. doi: 10.1038/s41467-025-56323-w.
4
Lymphomatoid Papulosis With DUSP22 Rearrangement in a Patient With a Historical Diagnosis of Primary Cutaneous Anaplastic Large Cell Lymphoma.
Cureus. 2024 Aug 2;16(8):e66022. doi: 10.7759/cureus.66022. eCollection 2024 Aug.
5
Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.
Int J Mol Sci. 2024 Jun 11;25(12):6447. doi: 10.3390/ijms25126447.
6
Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
Pathologie (Heidelb). 2023 Dec;44(Suppl 3):136-139. doi: 10.1007/s00292-023-01258-6. Epub 2023 Nov 27.
7
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Curr Hematol Malig Rep. 2023 Dec;18(6):252-263. doi: 10.1007/s11899-023-00712-9. Epub 2023 Oct 23.
8
Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
Hum Pathol. 2023 Nov;141:6-14. doi: 10.1016/j.humpath.2023.08.007. Epub 2023 Aug 24.
9
Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features.
Cancers (Basel). 2023 Aug 14;15(16):4098. doi: 10.3390/cancers15164098.
10
How molecular advances may improve the diagnosis and management of PTCL patients.
Front Oncol. 2023 Jun 23;13:1202964. doi: 10.3389/fonc.2023.1202964. eCollection 2023.
本文引用的文献
1
and rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Blood. 2017 Jul 27;130(4):554-557. doi: 10.1182/blood-2016-12-755496. Epub 2017 May 18.
2
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.
3
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.
Histopathology. 2015 May;66(6):846-55. doi: 10.1111/his.12529. Epub 2015 Feb 4.
4
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.
5
Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.
Am J Surg Pathol. 2013 Aug;37(8):1173-81. doi: 10.1097/PAS.0b013e318282d01e.
6
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.
J Clin Pathol. 2012 Mar;65(3):218-23. doi: 10.1136/jclinpath-2011-200353. Epub 2011 Nov 30.
7
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
Blood. 2011 Jan 20;117(3):915-9. doi: 10.1182/blood-2010-08-303305. Epub 2010 Oct 28.
8
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.
J Mol Diagn. 2006 May;8(2):141-51. doi: 10.2353/jmoldx.2006.050083.
9
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.
Nat Med. 2005 Jun;11(6):623-9. doi: 10.1038/nm1249. Epub 2005 May 15.
Zotero 插件